KILITCH DRUGS INDIA LTD
KILITCH · FMCG · NSE
₹189
Current Market Price
Under Review— We don’t have enough data to publish a fair value estimate for KILITCH yet. Reason: Data Limited.
Updated just now
YieldIQ Score
—
Piotroski F-Score
3/9
Economic Moat
Narrow
Confidence
21%
ROE
10.8%
Debt/Equity
0.32
WACC
9.2%
Market Cap
₹660.77 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
13.0%
Return on capital employed
EV / EBITDA
17.5×
Enterprise multiple
Debt / EBITDA
2.4×
Leverage vs earnings
Interest Coverage
7.8×
EBIT covers interest
Current Ratio
2.06×
Short-term liquidity
Asset Turnover
0.75×
Revenue per ₹ of assets
Revenue CAGR (3Y)
19.3%
3-year revenue growth
Revenue CAGR (5Y)
24.9%
5-year revenue growth
Ratio Trends
KILITCH · last 9 annual periods
ROE
10.8%
ROCE
13.0%
Operating Margin
—
Debt / Equity
0.32×
PE
23.3×
EV / EBITDA
12.0×
Historical Financials
KILITCH · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹113 Cr | ₹139 Cr | ₹154 Cr | ₹198 Cr | ₹235 Cr | +20.2% |
| EBITDA | ₹13.3 Cr | ₹20.5 Cr | ₹28.6 Cr | ₹42.6 Cr | ₹47.8 Cr | +37.8% |
| EBIT | ₹10.8 Cr | ₹16.9 Cr | ₹25.3 Cr | — | — | +23.7% |
| PAT | ₹7.4 Cr | ₹10.4 Cr | ₹14.6 Cr | ₹26.7 Cr | ₹30.2 Cr | +42.3% |
| EPS (diluted) | ₹4.73 | ₹6.71 | ₹9.17 | — | — | +18.0% |
| CFO | ₹5.8 Cr | ₹2.6 Cr | ₹-1.5 Cr | ₹17.5 Cr | ₹24.0 Cr | +42.7% |
| CapEx | ₹-8.2 Cr | ₹-3.8 Cr | ₹-6.5 Cr | ₹-46.9 Cr | ₹-99.5 Cr | — |
| FCF | ₹-2.4 Cr | ₹-1.2 Cr | ₹-8.0 Cr | ₹-29.3 Cr | ₹-75.5 Cr | — |
| Total Assets | ₹210 Cr | ₹220 Cr | ₹240 Cr | ₹313 Cr | ₹458 Cr | +21.5% |
| Total Debt | ₹20.4 Cr | ₹22.2 Cr | ₹31.6 Cr | ₹49.4 Cr | ₹88.7 Cr | +44.3% |
| Shareholders' Equity | ₹139 Cr | ₹152 Cr | ₹176 Cr | ₹202 Cr | ₹280 Cr | +19.1% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
KILITCH vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
AMANTA AMANTA | — | — | Pending | 6.8% | — |
ZIMLAB ZIMLAB | — | — | Pending | 4.8% | — |
ALBERTDAVD ALBERTDAVD | — | — | Pending | -0.4% | — |
VALIANTLAB VALIANTLAB | — | — | Pending | -0.9% | — |
MEDICAMEQ MEDICAMEQ | — | — | Pending | 3.4% | — |
Click a ticker to view its fair-value analysis.
Dividend History
2 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
—
Last payout
2019-09-20
₹0.24
Peak payout
₹0.24
Trailing yield
—
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
Risk Analysis
Volatility & drawdown
Risk profile of KILITCH →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for KILITCH →
Compare
Head-to-head with peers
Compare KILITCH side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse KILITCHNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.